Providing market intelligence for more than 35 years

In The News

Google share price: Company expands Chromecast technology to target home audio

Google first tested the potential of its streaming media technology with Chromecast, a $35 dongle that can be plugged into a television set to enable people to access digital video services such as YouTube or Netflix. Chromecast was introduced in 2013 and has become a huge success for the online search company. According to Parks Associates the device has emerged as the number two media-streaming device in the US, capturing 20 percent of sales to American homes with broadband access during the first three quarters of last year.

In yesterday’s trading Google shares fell 1.9 percent to $519.46, leaving the company with a market capitalisation of $358.23 billion. The current consensus estimate suggests that investors should buy equity in the company.

From the article "Google share price: Company expands Chromecast technology to target home audio" by Farquar McIntosh.

Previously In The News

EnergySage to Present at the Seventh Annual Smart Energy Summit

EnergySage announced today that John Gingrich, senior vice president of strategic partnerships, will present at the Parks Associates 2016 Smart Energy Summit: Engaging the Consumer, taking place Febru...

Parks Associates Confirmed As Knowledge Partner For Autonomous Car Detroit

Parks Associates is an internationally recognized market research firm specializing in emerging consumer technology products and services. The company’s expertise includes the Internet of Things (IoT)...

Streaming bills are piling up: Do you care?

In June, Parks Associates released a study that found video-streaming services in the U.S. will see revenue jump from $9 billion in 2014 to $19 billion in 2019. The company reported that 57% of househ...

Netflix Earnings Preview: Is Streaming Video Giant Still Snagging New Subscribers?

On top of that, the industry churn rate—a metric used to reflect cancelled subscriptions to streaming services overall—shot up 41% in Q1, the most recent statistic available, as consumers experimented...